What are the current treatments for ALS?

Amyotrophic Lateral Sclerosis (ALS) is a rare disease that affects movement and eventually breathing. This video provides information on ALS and the treatments that are currently available.

This video was made by McMaster Demystifying Medicine students Nikkita Mistri, Anand Rai, Mohamed Rahal and Davneet Poonia

Copyright McMaster University 2018

References:

Cruz, M. P. (2018). Edaravone (Radicava) A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis. Pharmacy and Therapeutics, 43(1), 25-28.

CTV Montreal. ALS patients fight to get drug approved in Canada. CTV News Montreal. Retrieved from: https://montreal.ctvnews.ca/al....s-patients-fight-to-

Dash, R. P., Babu, R. J., Srinivas, N. R. (2018). Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics. Clinical Pharmacokinetics, 1-14. https://doi.org/10.1007/s40262-018-0655-4

Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., Zoing, M. C. (2011). Amyotrophic Lateral Sclerosis. The Lancet, 377(9769), 942-955. https://doi.org/10.1016/S0140-6736(10)61156-7.

Puzic, S. (2017). Patients see hope in new ALS drug not approved for sale in Canada. CTV News. Retrieved from: https://www.ctvnews.ca/health/....patients-see-hope-in